European pharmaceutical stocks slumped, continuing a selloff that started with US-listed peers after President Donald Trump escalated his campaign to pressure drugmakers to lower prices in the country.
                         Latest posts by Toimitus (see all)
 Extralehdet Extralehdet
Extralehdet Extralehdet
				
